| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.75 | 0.003 | 0.811 | Alpha-N-acetylglucosaminidase inhibitor | 0.811 0.002 CID_54375198 | CID_54375198 | |
| 0.655 | 0.012 | 0.655 | Aldehyde oxidase inhibitor | |||
| 0.651 | 0.01 | 0.651 | 5 Hydroxytryptamine release stimulant | 0.382 0.049 CID_54375198 | ||
| 0.608 | 0.006 | 0.608 | Hypolipemic | 0.508 0.012 CID_54375198 | ||
| 0.571 | 0.003 | 0.571 | Alcohol oxidase inhibitor | 0.074 0.027 CID_54375198 | ||
| 0.567 | 0.016 | 0.567 | 5 Hydroxytryptamine release inhibitor | 0.516 0.028 CID_54375198 | ||
| 0.533 | 0.007 | 0.533 | Peroxidase inhibitor | |||
| 0.501 | 0.008 | 0.537 | Anesthetic general | 0.537 0.006 CID_54375198 | CID_54375198 | |
| 0.529 | 0.042 | 0.853 | Cyclophilin D inhibitor | 0.853 0.005 CID_54375198 | CID_54375198 | |
| 0.471 | 0.048 | 0.471 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.48 | 0.068 | 0.547 | Caspase 9 stimulant | 0.547 0.045 CID_54375198 | CID_54375198 | |
| 0.452 | 0.04 | 0.66 | Cholesterol antagonist | 0.66 0.011 CID_54375198 | CID_54375198 | |
| 0.45 | 0.05 | 0.512 | Histamine release inhibitor | 0.512 0.025 CID_54375198 | CID_54375198 | |
| 0.404 | 0.005 | 0.404 | GABA C receptor agonist | 0.112 0.055 CID_54375198 | ||
| 0.439 | 0.044 | 0.439 | Vasodilator, peripheral | 0.399 0.055 CID_54375198 | ||
| 0.392 | 0.003 | 0.51 | Triose-phosphate isomerase inhibitor | 0.51 0.002 CID_54375198 | CID_54375198 | |
| 0.413 | 0.027 | 0.413 | Cardiotonic | |||
| 0.429 | 0.049 | 0.429 | GABA C receptor rho-3 antagonist | |||
| 0.38 | 0.007 | 0.488 | UDP-glucose 4-epimerase inhibitor | 0.488 0.003 CID_54375198 | CID_54375198 | |
| 0.346 | 0.005 | 0.346 | Ferrochelatase inhibitor | |||
| 0.372 | 0.037 | 0.372 | Calcium channel activator | |||
| 0.329 | 0.006 | 0.329 | Nav1.1 sodium channel blocker | |||
| 0.325 | 0.005 | 0.325 | Adenylate kinase inhibitor | 0.218 0.013 CID_54375198 | ||
| 0.323 | 0.005 | 0.347 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.347 0.005 CID_54375198 | CID_54375198 | |
| 0.343 | 0.027 | 0.343 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.311 | 0.009 | 0.311 | Succinate dehydrogenase inhibitor | 0.154 0.105 CID_54375198 | ||
| 0.307 | 0.006 | 0.538 | NADH dehydrogenase inhibitor | 0.538 0.003 CID_54375198 | CID_54375198 | |
| 0.353 | 0.054 | 0.774 | Apoptosis antagonist | 0.774 0.004 CID_54375198 | CID_54375198 | |
| 0.303 | 0.01 | 0.303 | Nitric-oxide synthase stimulant | 0.258 0.027 CID_54375198 | ||
| 0.326 | 0.036 | 0.499 | DNA synthesis inhibitor | 0.499 0.013 CID_54375198 | CID_54375198 | |
| 0.295 | 0.005 | 0.295 | ABCA1 expression enhancer | |||
| 0.377 | 0.094 | 0.377 | Analgesic | 0.363 0.102 CID_54375198 | ||
| 0.338 | 0.058 | 0.338 | Nootropic | |||
| 0.304 | 0.031 | 0.304 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.316 | 0.045 | 0.316 | Superoxide dismutase inhibitor | |||
| 0.269 | 0.007 | 0.376 | Phosphofructokinase-1 inhibitor | 0.376 0.004 CID_54375198 | CID_54375198 | |
| 0.267 | 0.005 | 0.267 | Carbamoyl phosphate synthetase inhibitor | 0.121 0.015 CID_54375198 | ||
| 0.29 | 0.034 | 0.29 | RNA-directed DNA polymerase inhibitor | 0.244 0.053 CID_54375198 | ||
| 0.299 | 0.048 | 0.44 | Interleukin agonist | 0.44 0.014 CID_54375198 | CID_54375198 | |
| 0.254 | 0.006 | 0.254 | GABA C receptor antagonist | |||
| 0.257 | 0.01 | 0.263 | Mannose-6-phosphate isomerase inhibitor | 0.263 0.009 CID_54375198 | CID_54375198 | |
| 0.25 | 0.004 | 0.25 | Cathepsin D inhibitor | 0.103 0.018 CID_54375198 | ||
| 0.247 | 0.005 | 0.247 | Creatine kinase inhibitor | 0.095 0.065 CID_54375198 | ||
| 0.246 | 0.005 | 0.246 | Electrolyte absorption antagonist | |||
| 0.274 | 0.033 | 0.274 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.218 0.059 CID_54375198 | ||
| 0.245 | 0.005 | 0.245 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.262 | 0.024 | 0.316 | Protein kinase stimulant | 0.316 0.015 CID_54375198 | CID_54375198 | |
| 0.244 | 0.007 | 0.244 | Glutamate dehydrogenase inhibitor | 0.131 0.02 CID_54375198 | ||
| 0.235 | 0.004 | 0.235 | Biliverdin reductase inhibitor | 0.123 0.013 CID_54375198 | ||
| 0.228 | 0.003 | 0.228 | Aconitate hydratase inhibitor | 0.053 0.034 CID_54375198 | ||
| 0.235 | 0.01 | 0.235 | Histidine decarboxylase inhibitor | |||
| 0.252 | 0.028 | 0.543 | Amylase inhibitor | 0.543 0.005 CID_54375198 | CID_54375198 | |
| 0.258 | 0.034 | 0.265 | Neurotrophic factor enhancer | 0.265 0.031 CID_54375198 | CID_54375198 | |
| 0.242 | 0.019 | 0.339 | Hexokinase inhibitor | 0.339 0.007 CID_54375198 | CID_54375198 | |
| 0.239 | 0.017 | 0.341 | ATPase inhibitor | 0.341 0.004 CID_54375198 | CID_54375198 | |
| 0.233 | 0.012 | 0.233 | Nav1.6 sodium channel blocker | |||
| 0.244 | 0.029 | 0.376 | Interferon gamma antagonist | 0.376 0.012 CID_54375198 | CID_54375198 | |
| 0.225 | 0.011 | 0.225 | Catalase inhibitor | |||
| 0.3 | 0.087 | 0.437 | Vasodilator, coronary | 0.437 0.026 CID_54375198 | CID_54375198 | |
| 0.211 | 0.005 | 0.211 | Acyl-CoA dehydrogenase inhibitor | 0.097 0.017 CID_54375198 | ||
| 0.21 | 0.006 | 0.21 | Glutamate decarboxylase inhibitor | |||
| 0.242 | 0.039 | 0.242 | Insulin sensitizer | 0.178 0.098 CID_54375198 | ||
| 0.231 | 0.03 | 0.231 | Phospholipase C inhibitor | 0.186 0.055 CID_54375198 | ||
| 0.204 | 0.005 | 0.204 | Vasopressin 1 antagonist | |||
| 0.309 | 0.11 | 0.336 | Antiobesity | 0.336 0.094 CID_54375198 | CID_54375198 | |
| 0.205 | 0.006 | 0.205 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.179 0.007 CID_54375198 | ||
| 0.263 | 0.065 | 0.263 | Gastrin inhibitor | 0.181 0.177 CID_54375198 | ||
| 0.215 | 0.02 | 0.215 | Arachidonic acid antagonist | 0.166 0.069 CID_54375198 | ||
| 0.202 | 0.008 | 0.202 | GABA C receptor rho-1 antagonist | |||
| 0.271 | 0.078 | 0.271 | Insulysin inhibitor | |||
| 0.193 | 0.004 | 0.193 | Vasopressin 1A antagonist | |||
| 0.279 | 0.09 | 0.555 | Interleukin 2 agonist | 0.555 0.004 CID_54375198 | CID_54375198 | |
| 0.189 | 0.004 | 0.189 | Glycine transporter 1 inhibitor | |||
| 0.189 | 0.004 | 0.189 | Ca2+-transporting ATPase inhibitor | 0.189 0.005 CID_54375198 | ||
| 0.204 | 0.022 | 0.204 | Toll-Like receptor 2 antagonist | 0.106 0.095 CID_54375198 | ||
| 0.185 | 0.005 | 0.221 | Neuraminidase (influenza) inhibitor | 0.221 0.004 CID_54375198 | CID_54375198 | |
| 0.281 | 0.102 | 0.664 | Antithrombotic | 0.664 0.01 CID_54375198 | CID_54375198 | |
| 0.208 | 0.03 | 0.543 | Hemostatic | 0.543 0.004 CID_54375198 | CID_54375198 | |
| 0.196 | 0.022 | 0.196 | Aminopeptidase B inhibitor | |||
| 0.191 | 0.018 | 0.191 | Adenylate cyclase stimulant | 0.147 0.068 CID_54375198 | ||
| 0.194 | 0.021 | 0.239 | Microtubule formation inhibitor | 0.239 0.012 CID_54375198 | CID_54375198 | |
| 0.186 | 0.019 | 0.186 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.18 | 0.015 | 0.18 | Porphobilinogen synthase inhibitor | |||
| 0.19 | 0.028 | 0.19 | CF transmembrane conductance regulator agonist | 0.19 0.028 CID_54375198 | ||
| 0.191 | 0.029 | 0.191 | Cholesterol synthesis inhibitor | 0.129 0.057 CID_54375198 | ||
| 0.192 | 0.03 | 0.192 | Aldehyde dehydrogenase inhibitor | 0.139 0.054 CID_54375198 | ||
| 0.194 | 0.034 | 0.194 | Anesthetic local | |||
| 0.192 | 0.033 | 0.353 | Cell wall synthesis inhibitor | 0.353 0.008 CID_54375198 | CID_54375198 | |
| 0.24 | 0.083 | 0.715 | Hypoglycemic | 0.715 0.005 CID_54375198 | CID_54375198 | |
| 0.164 | 0.01 | 0.164 | Aminopeptidase I inhibitor | |||
| 0.16 | 0.008 | 0.177 | Glutamate release inhibitor | 0.177 0.005 CID_54375198 | CID_54375198 | |
| 0.172 | 0.02 | 0.172 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.22 | 0.069 | 0.22 | MAP kinase kinase 2 inhibitor | |||
| 0.155 | 0.005 | 0.168 | Neuraminidase inhibitor | 0.168 0.005 CID_54375198 | CID_54375198 | |
| 0.169 | 0.023 | 0.169 | Mucolytic | 0.153 0.031 CID_54375198 | ||
| 0.176 | 0.031 | 0.176 | Cystathionine beta-synthase inhibitor | 0.128 0.053 CID_54375198 | ||
| 0.148 | 0.004 | 0.148 | Fumarate hydratase inhibitor | 0.062 0.01 CID_54375198 | ||
| 0.145 | 0.003 | 0.177 | Glucose-6-phosphate isomerase inhibitor | 0.177 0.002 CID_54375198 | CID_54375198 | |
| 0.241 | 0.1 | 0.536 | Immunostimulant | 0.536 0.024 CID_54375198 | CID_54375198 | |
| 0.172 | 0.033 | 0.172 | Cathepsin H inhibitor | |||
| 0.161 | 0.025 | 0.161 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.141 | 0.005 | 0.141 | Liver X receptor agonist | |||
| 0.139 | 0.004 | 0.139 | Exportin-1 inhibitor | |||
| 0.156 | 0.022 | 0.156 | Sphingomyelinase inhibitor | 0.137 0.031 CID_54375198 | ||
| 0.152 | 0.02 | 0.152 | Alcohol dehydrogenase inhibitor | 0.121 0.034 CID_54375198 | ||
| 0.14 | 0.008 | 0.14 | Antidiuretic hormone antagonist | |||
| 0.152 | 0.02 | 0.152 | DOPA decarboxylase inhibitor | |||
| 0.174 | 0.045 | 0.174 | Nav1.2 sodium channel blocker | |||
| 0.136 | 0.007 | 0.136 | Secretase beta inhibitor | |||
| 0.213 | 0.084 | 0.431 | Peptidyltransferase inhibitor | 0.431 0.005 CID_54375198 | CID_54375198 | |
| 0.265 | 0.137 | 0.579 | Immunosuppressant | 0.579 0.016 CID_54375198 | CID_54375198 | |
| 0.131 | 0.004 | 0.131 | Vasopressin 2 antagonist | |||
| 0.174 | 0.047 | 0.174 | GABA C receptor rho-2 antagonist | |||
| 0.186 | 0.06 | 0.186 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.144 | 0.021 | 0.144 | Anabolic | 0.092 0.075 CID_54375198 | ||
| 0.195 | 0.072 | 0.195 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.155 | 0.033 | 0.3 | Expectorant | 0.3 0.009 CID_54375198 | CID_54375198 | |
| 0.137 | 0.017 | 0.137 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.144 | 0.024 | 0.144 | Androgen antagonist | |||
| 0.16 | 0.042 | 0.16 | Nav1.3 sodium channel blocker | |||
| 0.174 | 0.056 | 0.221 | Melanin inhibitor | 0.221 0.034 CID_54375198 | CID_54375198 | |
| 0.124 | 0.006 | 0.124 | Prostaglandin F2 alpha antagonist | |||
| 0.13 | 0.014 | 0.13 | Argininosuccinate synthase inhibitor | 0.08 0.025 CID_54375198 | ||
| 0.126 | 0.012 | 0.126 | Ornithine carbamoyltransferase inhibitor | 0.062 0.03 CID_54375198 | ||
| 0.188 | 0.073 | 0.68 | Hepatoprotectant | 0.68 0.004 CID_54375198 | CID_54375198 | |
| 0.127 | 0.013 | 0.15 | GABA aminotransferase inhibitor | 0.15 0.008 CID_54375198 | CID_54375198 | |
| 0.126 | 0.013 | 0.126 | Prostaglandin EP2 antagonist | |||
| 0.119 | 0.006 | 0.119 | Sphingosine 1-phosphate receptor 5 agonist | 0.071 0.016 CID_54375198 | ||
| 0.124 | 0.011 | 0.124 | Purinergic P2X1 antagonist | 0.073 0.029 CID_54375198 | ||
| 0.191 | 0.079 | 0.299 | Non-steroidal antiinflammatory agent | 0.299 0.028 CID_54375198 | CID_54375198 | |
| 0.135 | 0.024 | 0.135 | MAP kinase kinase 1 inhibitor | |||
| 0.155 | 0.045 | 0.155 | Pregnane X receptor agonist | |||
| 0.21 | 0.102 | 0.21 | Neuropeptide Y2 antagonist | |||
| 0.142 | 0.034 | 0.142 | Protease inhibitor | |||
| 0.169 | 0.061 | 0.215 | Diuretic | 0.215 0.039 CID_54375198 | CID_54375198 | |
| 0.141 | 0.033 | 0.141 | Nav1.5 sodium channel blocker | |||
| 0.243 | 0.136 | 0.243 | Sodium/bile acid cotransporter inhibitor | |||
| 0.151 | 0.044 | 0.151 | Adenylate cyclase inhibitor | |||
| 0.11 | 0.004 | 0.11 | Vasopressin 2 agonist | |||
| 0.115 | 0.009 | 0.115 | GABA B receptor agonist | |||
| 0.165 | 0.06 | 0.298 | Insulin secretagoues | 0.298 0.013 CID_54375198 | CID_54375198 | |
| 0.111 | 0.005 | 0.111 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.279 | 0.175 | 0.279 | Calcium channel L-type activator | |||
| 0.108 | 0.005 | 0.108 | Calcium channel P-type blocker | |||
| 0.108 | 0.005 | 0.219 | Alpha-mannosidase inhibitor | 0.219 0.003 CID_54375198 | CID_54375198 | |
| 0.123 | 0.02 | 0.123 | Keratolytic | |||
| 0.151 | 0.049 | 0.151 | Aurora-C kinase inhibitor | |||
| 0.168 | 0.066 | 0.168 | Interleukin 6 antagonist | 0.159 0.077 CID_54375198 | ||
| 0.184 | 0.085 | 0.184 | I kappa B kinase epsilon inhibitor | |||
| 0.144 | 0.045 | 0.154 | Beta amyloid protein antagonist | 0.154 0.038 CID_54375198 | CID_54375198 | |
| 0.307 | 0.209 | 0.894 | Antiinflammatory | 0.894 0.005 CID_54375198 | CID_54375198 | |
| 0.148 | 0.051 | 0.148 | Heat shock protein 70 antagonist | 0.144 0.061 CID_54375198 | ||
| 0.123 | 0.027 | 0.123 | Glutamate (mGluR7) agonist | |||
| 0.1 | 0.006 | 0.22 | Mannosidase inhibitor | 0.22 0.003 CID_54375198 | CID_54375198 | |
| 0.106 | 0.013 | 0.106 | Vanilloid 4 agonist | |||
| 0.128 | 0.035 | 0.128 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.151 | 0.059 | 0.151 | MAP kinase kinase 4 inhibitor | |||
| 0.096 | 0.005 | 0.096 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.232 | 0.141 | 0.611 | Transcription factor NF kappa B inhibitor | 0.611 0.03 CID_54375198 | CID_54375198 | |
| 0.182 | 0.091 | 0.182 | Psychostimulant | 0.141 0.125 CID_54375198 | ||
| 0.191 | 0.101 | 0.227 | Cyclic AMP phosphodiesterase inhibitor | 0.227 0.076 CID_54375198 | CID_54375198 | |
| 0.1 | 0.011 | 0.1 | Glutamate (mGluR6) antagonist | |||
| 0.106 | 0.018 | 0.106 | Glycine receptor agonist | 0.106 0.018 CID_54375198 | ||
| 0.096 | 0.009 | 0.096 | Sphingosine kinase 2 inhibitor | |||
| 0.09 | 0.003 | 0.09 | Cholesterol ester transfer protein antagonist | |||
| 0.109 | 0.024 | 0.125 | Na+ K+ transporting ATPase inhibitor | 0.125 0.014 CID_54375198 | CID_54375198 | |
| 0.097 | 0.012 | 0.097 | Glutamate (mGluR7) antagonist | |||
| 0.09 | 0.007 | 0.09 | Sphingosine 1-phosphate receptor agonist | |||
| 0.095 | 0.011 | 0.095 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.12 | 0.038 | 0.12 | Prolactin inhibitor | |||
| 0.113 | 0.032 | 0.132 | Phosphodiesterase 6D inhibitor | 0.132 0.017 CID_54375198 | CID_54375198 | |
| 0.113 | 0.032 | 0.113 | Ornithine decarboxylase inhibitor | |||
| 0.142 | 0.061 | 0.142 | Sodium channel (voltage-gated) blocker | |||
| 0.088 | 0.008 | 0.088 | Dihydroorotate oxidase inhibitor | |||
| 0.085 | 0.005 | 0.085 | Pregnane X receptor antagonist | |||
| 0.096 | 0.016 | 0.096 | Androgen agonist | |||
| 0.136 | 0.057 | 0.136 | Vanilloid 1 agonist | 0.127 0.072 CID_54375198 | ||
| 0.151 | 0.073 | 0.155 | Phospholipase A2 inhibitor | 0.155 0.069 CID_54375198 | CID_54375198 | |
| 0.104 | 0.026 | 0.117 | Interferon agonist | 0.117 0.019 CID_54375198 | CID_54375198 | |
| 0.083 | 0.007 | 0.083 | Adenylate cyclase 1 inhibitor | |||
| 0.101 | 0.024 | 0.101 | Estrogen-related receptor beta agonist | |||
| 0.101 | 0.025 | 0.101 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.107 | 0.031 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.115 0.023 CID_54375198 | CID_54375198 | |
| 0.077 | 0.002 | 0.077 | Vasopressin 1A agonist | 0.029 0.019 CID_54375198 | ||
| 0.081 | 0.006 | 0.081 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.122 | 0.047 | 0.429 | AMP-activated protein kinase stimulant | 0.429 0.004 CID_54375198 | CID_54375198 | |
| 0.102 | 0.027 | 0.102 | D-Ala-D-Ala ligase inhibitor | |||
| 0.093 | 0.019 | 0.093 | Phospholipase D inhibitor | |||
| 0.195 | 0.124 | 0.223 | Spasmolytic | 0.223 0.104 CID_54375198 | CID_54375198 | |
| 0.123 | 0.053 | 0.168 | Photosensitizer | 0.168 0.022 CID_54375198 | CID_54375198 | |
| 0.082 | 0.015 | 0.082 | Sphingosine kinase inhibitor | |||
| 0.086 | 0.019 | 0.097 | Interferon inducer | 0.097 0.014 CID_54375198 | CID_54375198 | |
| 0.1 | 0.033 | 0.136 | Glycine receptor antagonist | 0.136 0.011 CID_54375198 | CID_54375198 | |
| 0.18 | 0.114 | 0.368 | Antiamyloidogenic | 0.368 0.035 CID_54375198 | CID_54375198 | |
| 0.085 | 0.02 | 0.085 | Beta 3 adrenoreceptor antagonist | |||
| 0.099 | 0.035 | 0.099 | mTOR complex 2 inhibitor | |||
| 0.13 | 0.067 | 0.236 | Cyclooxygenase 3 inhibitor | 0.236 0.01 CID_54375198 | CID_54375198 | |
| 0.075 | 0.011 | 0.075 | Adenosine deaminase inhibitor | 0.063 0.018 CID_54375198 | ||
| 0.068 | 0.005 | 0.068 | Glutamate (mGluR8) agonist | |||
| 0.114 | 0.051 | 0.114 | Carbonic anhydrase XV inhibitor | |||
| 0.081 | 0.019 | 0.081 | MDM2 inhibitor | |||
| 0.068 | 0.007 | 0.068 | Liver X receptor antagonist | |||
| 0.071 | 0.01 | 0.071 | AICAR transformylase inhibitor | |||
| 0.125 | 0.064 | 0.222 | Alkylator | 0.222 0.021 CID_54375198 | CID_54375198 | |
| 0.071 | 0.01 | 0.071 | Cholesterol esterase inhibitor | |||
| 0.065 | 0.005 | 0.065 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.068 | 0.008 | 0.068 | HIV-1 protease inhibitor | |||
| 0.066 | 0.007 | 0.066 | Guanylate cyclase inhibitor | 0.063 0.009 CID_54375198 | ||
| 0.063 | 0.004 | 0.063 | HMG CoA reductase inhibitor | 0.033 0.025 CID_54375198 | ||
| 0.076 | 0.018 | 0.076 | Glucosylceramidase inhibitor | 0.055 0.038 CID_54375198 | ||
| 0.063 | 0.005 | 0.063 | Antidiuretic hormone agonist | |||
| 0.077 | 0.02 | 0.077 | Beta 1 adrenoreceptor antagonist | |||
| 0.075 | 0.017 | 0.077 | Toll-Like receptor 2 agonist | 0.077 0.017 CID_54375198 | CID_54375198 | |
| 0.082 | 0.024 | 0.082 | TRPA1 antagonist | |||
| 0.097 | 0.04 | 0.097 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.082 | 0.025 | 0.082 | Beta adrenoreceptor antagonist | |||
| 0.195 | 0.14 | 0.195 | Transcription factor STAT3 inhibitor | |||
| 0.068 | 0.013 | 0.068 | Immunoglobulin Fc receptor antagonist | |||
| 0.095 | 0.04 | 0.095 | Adrenaline agonist | |||
| 0.08 | 0.026 | 0.08 | Aryl hydrocarbon receptor antagonist | |||
| 0.086 | 0.033 | 0.086 | MAP kinase kinase 7 inhibitor | |||
| 0.056 | 0.005 | 0.16 | Sodium/glucose cotransporter inhibitor | 0.16 0.002 CID_54375198 | CID_54375198 | |
| 0.055 | 0.005 | 0.055 | Glutamate (mGluR1a) agonist | |||
| 0.054 | 0.004 | 0.054 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.082 | 0.033 | 0.082 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.062 | 0.013 | 0.062 | Thymidine kinase inhibitor | 0.037 0.036 CID_54375198 | ||
| 0.057 | 0.008 | 0.057 | Kainate receptor agonist | |||
| 0.054 | 0.006 | 0.054 | Vanilloid 3 antagonist | |||
| 0.097 | 0.05 | 0.097 | Calcium antagonist | |||
| 0.058 | 0.011 | 0.058 | Membrane dipeptidase inhibitor | |||
| 0.071 | 0.024 | 0.071 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.059 | 0.011 | 0.059 | Phosphoglycerate kinase inhibitor | |||
| 0.064 | 0.017 | 0.064 | Aldosterone antagonist | |||
| 0.051 | 0.005 | 0.051 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.09 | 0.043 | 0.09 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.053 | 0.007 | 0.053 | Plasmepsin I inhibitor | |||
| 0.067 | 0.021 | 0.067 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.052 | 0.007 | 0.054 | Uridine phosphorylase inhibitor | 0.054 0.007 CID_54375198 | CID_54375198 | |
| 0.06 | 0.015 | 0.06 | Dopamine beta hydroxylase inhibitor | |||
| 0.103 | 0.059 | 0.103 | Carbonic anhydrase III inhibitor | |||
| 0.08 | 0.035 | 0.08 | Potassium channel (Tandem pore domain) blocker | |||
| 0.064 | 0.02 | 0.064 | Beta 2 adrenoreceptor antagonist | |||
| 0.058 | 0.014 | 0.071 | Neuraminidase (Influenza A) inhibitor | 0.071 0.007 CID_54375198 | CID_54375198 | |
| 0.05 | 0.007 | 0.05 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.048 | 0.004 | 0.048 | Prostaglandin F2 alpha agonist | |||
| 0.047 | 0.005 | 0.047 | Prostaglandin EP4 agonist | |||
| 0.054 | 0.013 | 0.054 | Sphingosine kinase 1 inhibitor | |||
| 0.046 | 0.004 | 0.046 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.052 | 0.011 | 0.052 | Glutamate (mGluR3) antagonist | |||
| 0.054 | 0.013 | 0.054 | GABA uptake inhibitor | |||
| 0.049 | 0.009 | 0.049 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.055 | 0.016 | 0.055 | Retinoid X receptor agonist | |||
| 0.089 | 0.049 | 0.089 | Glutathione S-transferase inhibitor | |||
| 0.088 | 0.048 | 0.088 | Carbonic anhydrase VI inhibitor | |||
| 0.092 | 0.052 | 0.092 | Bromodomain-containing protein 2 inhibitor | |||
| 0.11 | 0.071 | 0.11 | TRPA1 agonist | |||
| 0.052 | 0.013 | 0.052 | Farnesoid X receptor agonist | |||
| 0.048 | 0.009 | 0.048 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.032 0.016 CID_54375198 | ||
| 0.043 | 0.005 | 0.043 | Glutamate (mGluR1) agonist | |||
| 0.054 | 0.015 | 0.054 | G protein-coupled receptor agonist | |||
| 0.048 | 0.01 | 0.048 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.055 | 0.018 | 0.055 | Geranyltranstransferase inhibitor | |||
| 0.061 | 0.024 | 0.061 | Glycine transporter inhibitor | |||
| 0.051 | 0.014 | 0.077 | Arginase inhibitor | 0.077 0.006 CID_54375198 | CID_54375198 | |
| 0.115 | 0.079 | 0.115 | MAP kinase kinase inhibitor | |||
| 0.044 | 0.007 | 0.044 | Liver X receptor alpha antagonist | |||
| 0.051 | 0.015 | 0.051 | Vascular adhesion protein 1 inhibitor | |||
| 0.04 | 0.004 | 0.04 | Vasopressin 1 agonist | |||
| 0.045 | 0.01 | 0.045 | ATP citrate lysase inhibitor | |||
| 0.058 | 0.023 | 0.058 | Squalene epoxidase inhibitor | 0.049 0.037 CID_54375198 | ||
| 0.079 | 0.044 | 0.079 | Cathepsin G inhibitor | |||
| 0.061 | 0.027 | 0.061 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.049 | 0.015 | 0.049 | Heme oxygenase inhibitor | |||
| 0.037 | 0.003 | 0.037 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.061 | 0.027 | 0.061 | Epithelial sodium channel blocker | |||
| 0.094 | 0.061 | 0.094 | Potassium channel (Ca-activated) activator | |||
| 0.065 | 0.032 | 0.065 | Beta 2 adrenoreceptor agonist | |||
| 0.051 | 0.018 | 0.051 | Liver X receptor alpha agonist | |||
| 0.118 | 0.086 | 0.118 | Sodium channel blocker | |||
| 0.057 | 0.024 | 0.057 | Potassium channel (Inward rectifier) activator | |||
| 0.044 | 0.012 | 0.044 | Prostaglandin agonist | |||
| 0.077 | 0.046 | 0.077 | Nav1.8 sodium channel blocker | |||
| 0.06 | 0.029 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.05 | 0.018 | 0.05 | Nerve growth factor antagonist | |||
| 0.145 | 0.114 | 0.145 | Neurotensin receptor agonist | |||
| 0.037 | 0.005 | 0.037 | Hedgehog signaling activator | |||
| 0.049 | 0.018 | 0.049 | Dopamine D5 agonist | |||
| 0.06 | 0.029 | 0.06 | Leukotriene C antagonist | |||
| 0.054 | 0.023 | 0.054 | Potassium channel (ATP-sensitive) activator | |||
| 0.063 | 0.033 | 0.063 | Carbonic anhydrase VB inhibitor | |||
| 0.068 | 0.038 | 0.068 | NMDA receptor glycine site agonist | |||
| 0.039 | 0.009 | 0.116 | Sodium/glucose cotransporter 2 inhibitor | 0.116 0.002 CID_54375198 | CID_54375198 | |
| 0.038 | 0.008 | 0.038 | Purinergic P2Y15 antagonist | |||
| 0.036 | 0.006 | 0.036 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 CID_54375198 | ||
| 0.056 | 0.026 | 0.056 | CD45 antagonist | |||
| 0.061 | 0.031 | 0.061 | Thromboxane antagonist | |||
| 0.046 | 0.016 | 0.046 | Retinoid X receptor antagonist | |||
| 0.128 | 0.099 | 0.128 | Thiol protease inhibitor | |||
| 0.064 | 0.035 | 0.064 | Cathepsin E inhibitor | |||
| 0.036 | 0.007 | 0.036 | Nicotinic acid receptor 2 antagonist | |||
| 0.049 | 0.02 | 0.049 | GABA B receptor antagonist | |||
| 0.04 | 0.012 | 0.04 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.053 | 0.024 | 0.061 | Microtubule stabilization | 0.061 0.013 CID_54375198 | CID_54375198 | |
| 0.078 | 0.05 | 0.078 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.046 | 0.018 | 0.046 | Cathepsin F inhibitor | |||
| 0.039 | 0.011 | 0.039 | Glutamate (mGluR3) agonist | |||
| 0.054 | 0.027 | 0.054 | Topoisomerase II beta inhibitor | |||
| 0.031 | 0.004 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 CID_54375198 | ||
| 0.044 | 0.017 | 0.044 | Retinoid X alpha receptor agonist | |||
| 0.093 | 0.066 | 0.093 | Bile acid receptor antagonist | |||
| 0.113 | 0.087 | 0.192 | DNA repair enzyme inhibitor | 0.192 0.01 CID_54375198 | CID_54375198 | |
| 0.046 | 0.02 | 0.046 | Alpha 1d adrenoreceptor agonist | |||
| 0.055 | 0.028 | 0.055 | Bombesin 2 receptor antagonist | |||
| 0.041 | 0.014 | 0.041 | Retinoid X alpha receptor antagonist | |||
| 0.055 | 0.029 | 0.055 | Antimetabolite | 0.048 0.033 CID_54375198 | ||
| 0.027 | 0.002 | 0.027 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.147 | 0.122 | 0.147 | P-glycoprotein inhibitor | |||
| 0.035 | 0.01 | 0.035 | Prostaglandin EP2 agonist | |||
| 0.067 | 0.042 | 0.067 | Leukotriene antagonist | |||
| 0.056 | 0.031 | 0.189 | Heparanase inhibitor | 0.189 0.002 CID_54375198 | CID_54375198 | |
| 0.058 | 0.034 | 0.058 | CC chemokine 2 receptor antagonist | |||
| 0.038 | 0.014 | 0.038 | Prostaglandin D2 agonist | |||
| 0.043 | 0.018 | 0.043 | p53 inhibitor | |||
| 0.028 | 0.004 | 0.028 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.06 | 0.036 | 0.06 | Ryanodine receptor antagonist | |||
| 0.126 | 0.103 | 0.371 | Thrombolytic | 0.371 0.014 CID_54375198 | CID_54375198 | |
| 0.042 | 0.019 | 0.042 | Calcitonin receptor agonist | |||
| 0.047 | 0.025 | 0.047 | Beta adrenoreceptor agonist | |||
| 0.075 | 0.053 | 0.075 | Carbonic anhydrase XIII inhibitor | 0.067 0.062 CID_54375198 | ||
| 0.028 | 0.006 | 0.028 | Calcium-sensing receptor antagonist | |||
| 0.064 | 0.042 | 0.064 | Transcription factor RelA inhibitor | |||
| 0.052 | 0.03 | 0.052 | HCV NS3/NS4A protease inhibitor | |||
| 0.032 | 0.012 | 0.032 | Estrogen-related receptor gamma antagonist | |||
| 0.071 | 0.05 | 0.071 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.025 | 0.004 | 0.025 | Thromboxane A2 agonist | |||
| 0.025 | 0.004 | 0.025 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 CID_54375198 | ||
| 0.038 | 0.018 | 0.038 | Free fatty acid receptor 1 antagonist | |||
| 0.041 | 0.02 | 0.107 | Antibiotic Aminoglycoside-like | 0.107 0.003 CID_54375198 | CID_54375198 | |
| 0.025 | 0.005 | 0.025 | Carbonic anhydrase VIII inhibitor | |||
| 0.025 | 0.005 | 0.025 | Carbonic anhydrase X inhibitor | |||
| 0.067 | 0.047 | 0.067 | Nav1.7 sodium channel blocker | |||
| 0.039 | 0.019 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.039 0.019 CID_54375198 | ||
| 0.06 | 0.04 | 0.06 | Carbonic anhydrase stimulant | |||
| 0.03 | 0.01 | 0.03 | Prostaglandin E2 agonist | |||
| 0.033 | 0.014 | 0.033 | Lysine carboxypeptidase inhibitor | |||
| 0.063 | 0.043 | 0.063 | NMDA receptor agonist | |||
| 0.049 | 0.03 | 0.064 | Cytokine production stimulant | 0.064 0.01 CID_54375198 | CID_54375198 | |
| 0.037 | 0.018 | 0.037 | Liver X receptor beta agonist | |||
| 0.023 | 0.005 | 0.03 | Telomerase stimulant | 0.03 0.003 CID_54375198 | CID_54375198 | |
| 0.025 | 0.007 | 0.025 | Cyclin T1 inhibitor | |||
| 0.046 | 0.028 | 0.046 | Secretase gamma inhibitor | |||
| 0.029 | 0.011 | 0.04 | Vanilloid 2 agonist | 0.04 0.004 CID_54375198 | CID_54375198 | |
| 0.026 | 0.009 | 0.026 | Isoleucine-tRNA ligase inhibitor | |||
| 0.032 | 0.014 | 0.032 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.092 | 0.074 | 0.092 | Nitric-oxide synthase inhibitor | |||
| 0.058 | 0.041 | 0.058 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.048 CID_54375198 | ||
| 0.128 | 0.111 | 0.128 | MAP kinase 3 inhibitor | |||
| 0.067 | 0.05 | 0.067 | Carbonic anhydrase VA inhibitor | |||
| 0.033 | 0.017 | 0.033 | Liver X receptor beta antagonist | |||
| 0.03 | 0.015 | 0.03 | Prostaglandin EP4 antagonist | |||
| 0.057 | 0.042 | 0.057 | Botulinum neurotoxin type A inhibitor | |||
| 0.072 | 0.057 | 0.072 | CYP2A6 inhibitor | |||
| 0.024 | 0.009 | 0.024 | Retinoid X beta receptor antagonist | |||
| 0.047 | 0.032 | 0.047 | Thymidylate synthase inhibitor | |||
| 0.091 | 0.077 | 0.091 | Gastric antisecretory | |||
| 0.036 | 0.022 | 0.036 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.024 | 0.01 | 0.024 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.02 | 0.007 | 0.02 | Vitamin D receptor agonist | 0.018 0.009 CID_54375198 | ||
| 0.079 | 0.066 | 0.079 | CC chemokine 5 receptor agonist | |||
| 0.064 | 0.051 | 0.064 | Acetylcholine M5 receptor agonist | |||
| 0.083 | 0.07 | 0.083 | Potassium channel activator | |||
| 0.057 | 0.045 | 0.057 | Heat shock protein 90 beta antagonist | |||
| 0.021 | 0.009 | 0.039 | Antibiotic Anthracycline-like | 0.039 0.002 CID_54375198 | CID_54375198 | |
| 0.02 | 0.007 | 0.02 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.017 | 0.005 | 0.017 | Glutamate (mGluR6) agonist | |||
| 0.025 | 0.014 | 0.025 | Aminopeptidase P inhibitor | |||
| 0.062 | 0.051 | 0.062 | Carbonic anhydrase V inhibitor | |||
| 0.029 | 0.018 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.015 | 0.005 | 0.015 | Thromboxane agonist | |||
| 0.077 | 0.067 | 0.077 | Inducible nitric-oxide synthase inhibitor | |||
| 0.027 | 0.017 | 0.027 | Thymidine phosphorylase inhibitor | |||
| 0.179 | 0.169 | 0.179 | Transcription factor STAT inhibitor | |||
| 0.038 | 0.028 | 0.038 | Leukotriene C4 antagonist | |||
| 0.036 | 0.026 | 0.036 | Renin inhibitor | |||
| 0.218 | 0.209 | 0.609 | Antibacterial | 0.609 0.018 CID_54375198 | CID_54375198 | |
| 0.051 | 0.041 | 0.051 | Ribonucleotide reductase inhibitor | |||
| 0.043 | 0.034 | 0.151 | Phosphorylase inhibitor | 0.151 0.007 CID_54375198 | CID_54375198 | |
| 0.05 | 0.041 | 0.05 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.043 | 0.034 | 0.043 | Dihydroorotase inhibitor | |||
| 0.039 | 0.031 | 0.039 | Glutamate (mGluR1a) antagonist | |||
| 0.033 | 0.024 | 0.033 | Protein kinase (CK2) beta inhibitor | |||
| 0.032 | 0.024 | 0.032 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.017 | 0.009 | 0.017 | Purinergic P2Y1 agonist | |||
| 0.042 | 0.035 | 0.042 | Oleamide hydrolase inhibitor | |||
| 0.06 | 0.053 | 0.06 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.036 | 0.029 | 0.036 | Glutamate (mGluR group II) antagonist | |||
| 0.042 | 0.035 | 0.042 | Glutamate (mGluR group III) antagonist | |||
| 0.044 | 0.037 | 0.044 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.097 | 0.09 | 0.097 | Electron transport complex I inhibitor | |||
| 0.017 | 0.011 | 0.017 | G-protein-coupled receptor 120 agonist | |||
| 0.071 | 0.065 | 0.071 | Estrogen receptor alpha antagonist | |||
| 0.03 | 0.024 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.016 | 0.011 | 0.016 | Prostacyclin agonist | |||
| 0.038 | 0.033 | 0.038 | CF transmembrane conductance regulator antagonist | |||
| 0.038 | 0.034 | 0.038 | Oxytocin agonist | |||
| 0.054 | 0.049 | 0.054 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.033 | 0.029 | 0.033 | Nicotinic acid receptor agonist | |||
| 0.078 | 0.074 | 0.078 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.012 | 0.008 | 0.012 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.057 | 0.054 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.038 | 0.035 | 0.038 | Carbonic anhydrase IV inhibitor | |||
| 0.038 | 0.035 | 0.038 | Plasmepsin II inhibitor | |||
| 0.088 | 0.085 | 0.304 | Monophenol monooxygenase inhibitor | 0.304 0.017 CID_54375198 | CID_54375198 | |
| 0.04 | 0.038 | 0.04 | Glutamate (mGluR4) antagonist | |||
| 0.02 | 0.018 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.087 | 0.085 | 0.087 | Falcipain 3 inhibitor | |||
| 0.049 | 0.047 | 0.051 | Leukotriene B4 antagonist | 0.051 0.041 CID_54375198 | CID_54375198 | |
| 0.063 | 0.061 | 0.063 | Amidase inhibitor | |||
| 0.026 | 0.024 | 0.026 | Glucagon receptor antagonist | |||
| 0.011 | 0.01 | 0.011 | Purine nucleoside phosphorylase inhibitor | |||
| 0.027 | 0.026 | 0.027 | MAP3K8 inhibitor | |||
| 0.034 | 0.033 | 0.034 | Delayed rectifier potassium channel blocker | |||
| 0.083 | 0.082 | 0.083 | Potassium channel (Voltage-sensitive) activator | |||
| 0.009 | 0.01 | 0.012 | Purinergic P2Y2 agonist | 0.012 0.005 CID_54375198 | CID_54375198 | |
| 0.076 | 0.079 | 0.211 | Transcription factor NF kappa B stimulant | 0.211 0.008 CID_54375198 | CID_54375198 | |
| 0.095 | 0.101 | 0.115 | Acetylcholine release stimulant | 0.115 0.057 CID_54375198 | CID_54375198 | |
| 0.012 | 0.02 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 CID_54375198 | CID_54375198 | |
| 0.086 | 0.096 | 0.233 | Beta glucuronidase inhibitor | 0.233 0.009 CID_54375198 | CID_54375198 | |
| 0.126 | 0.136 | 0.158 | DNA methyltransferase I inhibitor | 0.158 0.096 CID_54375198 | CID_54375198 | |
| 0.059 | 0.07 | 0.106 | Histone deacetylase stimulant | 0.106 0.024 CID_54375198 | CID_54375198 | |
| 0.059 | 0.07 | 0.106 | Histone deacetylase SIRT1 stimulant | 0.106 0.024 CID_54375198 | CID_54375198 | |
| 0.078 | 0.1 | 0.137 | Xanthine oxidase inhibitor | 0.137 0.04 CID_54375198 | CID_54375198 | |
| 0.035 | 0.06 | 0.087 | Carbonic anhydrase XIV inhibitor | 0.087 0.014 CID_54375198 | CID_54375198 | |
| 0.038 | 0.067 | 0.119 | Factor IXa inhibitor | 0.119 0.006 CID_54375198 | CID_54375198 | |
| 0.147 | 0.177 | 0.174 | DNA damaging | 0.174 0.14 CID_54375198 | CID_54375198 | |
| 0.08 | 0.115 | 0.228 | Toll-Like receptor 4 antagonist | 0.228 0.004 CID_54375198 | CID_54375198 | |
| 0.009 | 0.045 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.011 CID_54375198 | CID_54375198 | |
| 0.118 | 0.156 | 0.22 | DNA methylase inhibitor | 0.22 0.067 CID_54375198 | CID_54375198 | |
| 0.039 | 0.077 | 0.501 | Selectin antagonist | 0.501 0.003 CID_54375198 | CID_54375198 | |
| 0.014 | 0.054 | 0.083 | Protein 30S ribosomal subunit inhibitor | 0.083 0.004 CID_54375198 | CID_54375198 | |
| 0.086 | 0.143 | 0.145 | Alkaline phosphatase inhibitor | 0.145 0.063 CID_54375198 | CID_54375198 | |
| 0.098 | 0.168 | 0.37 | NOS3 expression enhancer | 0.37 0.01 CID_54375198 | CID_54375198 | |
| 0.026 | 0.098 | 0.191 | Protein 50S ribosomal subunit inhibitor | 0.191 0.005 CID_54375198 | CID_54375198 | |
| 0.008 | 0.085 | 0.049 | Squalene synthetase inhibitor | 0.049 0.015 CID_54375198 | CID_54375198 | |
| 0.055 | 0.135 | 0.112 | Mediator release inhibitor | 0.112 0.056 CID_54375198 | CID_54375198 | |
| 0.002 | 0.089 | 0.021 | Antibiotic Macrolide-like | 0.021 0.006 CID_54375198 | CID_54375198 | |
| 0.032 | 0.12 | 0.327 | Antineoplastic antibiotic | 0.327 0.008 CID_54375198 | CID_54375198 | |
| 0.097 | 0.185 | 0.556 | Nitric oxide antagonist | 0.556 0.012 CID_54375198 | CID_54375198 | |
| 0.039 | 0.131 | 0.135 | Adenine nucleotide translocase inhibitor | 0.135 0.003 CID_54375198 | CID_54375198 | |
| 0.008 | 0.102 | 0.025 | Corticosteroid-like | 0.025 0.01 CID_54375198 | CID_54375198 | |
| 0.042 | 0.138 | 0.073 | Lipocortins synthesis agonist | 0.073 0.018 CID_54375198 | CID_54375198 | |
| 0.071 | 0.196 | 0.158 | Interleukin 4 antagonist | 0.158 0.043 CID_54375198 | CID_54375198 | |
| 0.016 | 0.16 | 0.081 | Aldose reductase inhibitor | 0.081 0.023 CID_54375198 | CID_54375198 | |
| 0.052 | 0.198 | 0.201 | DNA polymerase I inhibitor | 0.201 0.028 CID_54375198 | CID_54375198 | |
| 0.009 | 0.171 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 CID_54375198 | CID_54375198 | |
| 0.015 | 0.216 | 0.05 | Toll-Like receptor 4 agonist | 0.05 0.004 CID_54375198 | CID_54375198 | |
| 0.02 | 0.227 | 0.069 | Nitric oxide donor | 0.069 0.034 CID_54375198 | CID_54375198 | |
| 0.048 | 0.298 | 0.834 | Angiogenesis stimulant | 0.834 0.003 CID_54375198 | CID_54375198 | |
| 0.081 | 0.36 | 0.401 | Alpha-glucosidase inhibitor | 0.401 0.114 CID_54375198 | CID_54375198 | |
| 0.018 | 0.312 | 0.123 | Protein-tyrosine phosphatase 1B inhibitor | 0.123 0.061 CID_54375198 | CID_54375198 | |
| 0.03 | 0.333 | 0.141 | Uric acid excretion stimulant | 0.141 0.027 CID_54375198 | CID_54375198 | |
| 0.05 | 0.405 | 0.405 | Vasodilator | 0.405 0.022 CID_54375198 | CID_54375198 | |
| 0.049 | 0.422 | 0.669 | Antioxidant | 0.669 0.007 CID_54375198 | CID_54375198 | |
| 0.022 | 0.423 | 0.137 | Cyclooxygenase 2 inhibitor | 0.137 0.065 CID_54375198 | CID_54375198 | |
| 0.019 | 0.458 | 0.179 | Cell adhesion molecule inhibitor | 0.179 0.011 CID_54375198 | CID_54375198 | |
| 0.024 | 0.464 | 0.145 | Cyclooxygenase inhibitor | 0.145 0.074 CID_54375198 | CID_54375198 | |
| 0.062 | 0.518 | 0.6 | Immunomodulator | 0.6 0.011 CID_54375198 | CID_54375198 | |
| 0.018 | 0.479 | 0.119 | Protein-tyrosine phosphatase inhibitor | 0.119 0.114 CID_54375198 | CID_54375198 | |
| 0.029 | 0.491 | 0.342 | Platelet antagonist | 0.342 0.04 CID_54375198 | CID_54375198 | |
| 0.026 | 0.518 | 0.313 | Cell adhesion inhibitor | 0.313 0.009 CID_54375198 | CID_54375198 | |
| 0.013 | 0.511 | 0.094 | Glucose-6-phosphate translocase inhibitor | 0.094 0.007 CID_54375198 | CID_54375198 | |
| 0.033 | 0.535 | 0.528 | Tumour necrosis factor alpha release inhibitor | 0.528 0.012 CID_54375198 | CID_54375198 | |
| 0.017 | 0.539 | 0.27 | Lipid peroxidase inhibitor | 0.27 0.023 CID_54375198 | CID_54375198 | |
| 0.022 | 0.551 | 0.616 | Free radical scavenger | 0.616 0.008 CID_54375198 | CID_54375198 | |
| 0.012 | 0.547 | 0.143 | Topoisomerase II alpha inhibitor | 0.143 0.024 CID_54375198 | CID_54375198 | |
| 0.074 | 0.631 | 0.158 | CC chemokine 6 receptor antagonist | 0.158 0.014 CID_54375198 | CID_54375198 | |
| 0.049 | 0.667 | 0.272 | Caspase 3 stimulant | 0.272 0.095 CID_54375198 | CID_54375198 | |
| 0.008 | 0.673 | 0.266 | Topoisomerase II inhibitor | 0.266 0.022 CID_54375198 | CID_54375198 | |
| 0.005 | 0.764 | 0.241 | Topoisomerase I inhibitor | 0.241 0.018 CID_54375198 | CID_54375198 | |
| 0.005 | 0.83 | 0.275 | Anticoagulant | 0.275 0.033 CID_54375198 | CID_54375198 | |
| 0.012 | 0.843 | 0.414 | Platelet adhesion inhibitor | 0.414 0.01 CID_54375198 | CID_54375198 | |
| 0.012 | 0.869 | 0.644 | Apoptosis agonist | 0.644 0.04 CID_54375198 | CID_54375198 | |
| 0.005 | 0.952 | 0.273 | Angiogenesis inhibitor | 0.273 0.107 CID_54375198 | CID_54375198 | |
| 0.002 | 0.953 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.011 CID_54375198 | CID_54375198 | |
| 0.004 | 0.969 | 0.103 | Multidrug resistance-associated protein 1 inhibitor | 0.103 0.074 CID_54375198 | CID_54375198 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |